« Back
Home /
Adalimumab (anti-TNF-alpha)

Adalimumab (anti-TNF-alpha)

Item no.	A2010-5
Manufacturer	Selleckchem
CASRN	331731-18-1
Amount	1mg x 5
Quantity options	1mg 1mg x 25 1mg x 5
Category	Oncology Neuroscience Neuroinflammation Metabolism Diabetes By Cell Type Cell Biology Obesity Cell Culture Cytokines Cell Status Necrosis Apoptosis Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	LU200134, D2E7
Available
Manufacturer - Targets	TNF
Storage Conditions	Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
Information	Adalimumab (anti-TNF-alpha) is the first fully human, recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha, MW: 144.19 KD.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1mg x 5

available

Delivery expected until 1/10/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Recommend by mail